hoodb.com

Proteostasis perturbation of N-Myc leveraging HSP70 mediated protein turnover improves treatment of neuroendocrine prostate cancer

|

You are leaving and open the following URL" of about "Prostate cancer" news

news.google.com/rss/articles/CBMiX0FVX3lxTE9fVWhZTndQTVRvMmg0MHVaYTY3ZnRzOG9Mb2Jaa3hLVWk2c3M1WjlyeDNlV2VnX0ZyamJ3SkNwU1oyeG82YUhIN0tLNEVrS2FpT3N2dWZ6czNwTW9VRFJ3?oc=5


Continue Opne >

Prostate cancer: Proteostasis perturbation of N-Myc leveraging HSP70 mediated protein turnover improves treatment of neuroendocrine prostate cancer


More Prostate cancer news:


About Prostate cancer

from

Warning: file_get_contents(aCache/search/ca/Prostate cancer): Failed to open stream: Permission denied in /var/www/hoodb/function.php on line 340

Prostate cancer, Proteostasis perturbation of N-Myc leveraging HSP70 mediated protein turnover improves treatment of neuroendocrine prostate cancer 2022 Prostate cancer

Proteostasis perturbation of N-Myc leveraging HSP70 mediated protein turnover improves treatment of neuroendocrine prostate cancer

Choose Your Country or Region


Back to Top



Proteostasis perturbation of N-Myc leveraging HSP70 mediated protein turnover improves treatment of neuroendocrine prostate cancer

Copyright © 2020-2021 hoodb.com. All Rights Reserved.